Standout Papers

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castr... 2008 2026 2014 2020 1.7k
  1. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group (2008)
    Howard I. Scher, Susan Halabi et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 19 from Science/Nature 80 standout
Sub-graph 1 of 17

Citing Papers

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance
2023 StandoutNature
Androgen receptor activity in T cells limits checkpoint blockade efficacy
2022 StandoutNature
3 intermediate papers

Works of Daniel Petrylak being referenced

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout

Author Peers

Author Last Decade Papers Cites
Daniel Petrylak 1880 441 804 716 8 2.3k
Martin Roessner 2190 499 948 887 11 2.8k
Youn C. Park 2635 402 762 754 20 3.0k
Liji Shen 2728 607 1240 1099 35 3.4k
Bryan Selby 3215 838 905 1106 10 3.6k
Ivo Kocák 2416 706 1363 926 40 3.2k
Aseem Anand 1708 585 1018 396 18 2.4k
J Horti 3561 995 1592 1155 17 4.5k
Stephen D. Rubin 1312 1101 2583 791 17 3.9k
Gladys Urbanowitz 2175 1904 1980 409 12 4.1k
Michael Rader 988 325 1788 654 18 2.3k

All Works

Loading papers...

Rankless by CCL
2026